Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster Presentations - Physicians/Scientists/Pharmacists

Syntheses, in vitro evaluation and radioiodination of halogenated benzamide derivatives for the visualization of D2-like dopamine receptors with SPECT

Daniela Stark, Markus Piel, Ulrich Schmitt, Harald Huebner, Peter Gmeiner, Hartmut Lueddens and Frank Roesch
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 496P;
Daniela Stark
1Institute of Nuclear Chemistry, University of Mainz, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Piel
1Institute of Nuclear Chemistry, University of Mainz, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Schmitt
2Department of Psychiatry, University of Mainz, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Huebner
3Departnent of Medicinal Chemistry, University of Erlangen, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Gmeiner
3Departnent of Medicinal Chemistry, University of Erlangen, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hartmut Lueddens
2Department of Psychiatry, University of Mainz, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Roesch
1Institute of Nuclear Chemistry, University of Mainz, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1819

Objectives: The benzamides [18F]fallypride ([18F]FP) and [18F]desmethoxyfallypride ([18F]DMFP) have found application as D2-selective PET-radioligands imaging dopamine receptors in the brain. For SPECT [123I]IBZM is the most commonly applied radioligand. Employing the favourable properties of [18F]FP and [18F]DMFP and thereby offering an interesting alternative to IBZM two iodinated analogues of the fluorinated allylic derivatives, N-allylepidepride (NAE) and N-allyldesmethoxyepidepride (NADE), were synthesized. Syntheses of bromine and chlorine analogues were performed as well.

Methods: Precursors and reference compounds were synthesized by coupling the respective benzoic acid derivative with (S)-2-aminomethyl-1-allylpyrrolidine. The benzoic acid derivatives were synthesized by methylating and/or oxidizing the corresponding aldehydes or carboxylic acids. Chloro-ethylformiate was employed to activate the benzoic acid derivatives before reacting them with (S)-2-aminomethyl-1-allylpyrrolidine. To obtain the stannous precursors the reference compounds were reacted with hexabutyldistannane using tetrakis(triphenylphosphine)palladium(0) as catalyst. Lipophilicities were determined using the HPLC-method. Affinities of the synthesized benzamides to dopamine receptor subtypes as well as to serotonergic and adrenergic receptor subtypes were examined. Due to easier handling and longer half-life radioiodinations were carried out using [131I]NaI in a phosphate buffer system with chloroamine-T as oxidizing agent. Radioiodination experiments with [123I]NaI were conducted as well.

Results: For the D2-receptor (hD2short) ki-values were 0.7 nM for NAE, 19 nM for NADE, 2.2 nM for FP and 30 nM for DMFP. LogD7.4-values for NAE, NADE, FP and DMFP were determined as 2.81, 2.70, 2.66 and 2.63 respectively. Radiochemical yields for [131I]NAE and [131I]NADE were moderate to good. Autoradiography in rat brain showed excellent visualization of the dopamine receptor regions. Ex vivo biodistribution studies in Sprague Dawley rats with both radioiodinated compounds showed results in compliance with those obtained for studies with [18F]FP and [18F]DMFP.

Conclusions: The promising results of the in vitro studies for NAE and the new compound NADE as well as the brominated derivatives justify further investigations.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Syntheses, in vitro evaluation and radioiodination of halogenated benzamide derivatives for the visualization of D2-like dopamine receptors with SPECT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Syntheses, in vitro evaluation and radioiodination of halogenated benzamide derivatives for the visualization of D2-like dopamine receptors with SPECT
Daniela Stark, Markus Piel, Ulrich Schmitt, Harald Huebner, Peter Gmeiner, Hartmut Lueddens, Frank Roesch
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 496P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Syntheses, in vitro evaluation and radioiodination of halogenated benzamide derivatives for the visualization of D2-like dopamine receptors with SPECT
Daniela Stark, Markus Piel, Ulrich Schmitt, Harald Huebner, Peter Gmeiner, Hartmut Lueddens, Frank Roesch
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 496P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster Presentations - Physicians/Scientists/Pharmacists

  • Selective internal radiotherapy (SIRT) of liver metastases and hepatocellular carcinoma: Is the posttherapeutic distribution of SIR Spheres® related to the pretherapeutic deposition of MAA in FDG positive lesions?
  • Mononuclear Tc-99m-chelate-conjugated oligo-aspartic acid as a new bone imaging agent
  • Tritium labeled choline and fluoroethylcholine – In vitro evaluation for visualization of prostate cancer with PET
Show more Poster Presentations - Physicians/Scientists/Pharmacists

Radiopharmaceutical Chemistry Track

  • Preparation of high specific activity Fluorine-18 nanoparticles using click chemistry
  • Radionuclide impurities of 210Po produced by neutron irradiation of 209Bi for use in targeted alpha-particle radiotherapy
  • Styrylbenzoxazole derivatives for beta-amyloid plaque imaging
Show more Radiopharmaceutical Chemistry Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire